I-FDA igunyaze i-COVID-19 Booster Shot yaBantu Abangavumelekile

-Delile

• Buyekeza kwe-

Ngolwazi olubonakala lusha mayelana ne-COVID-19 eqhamuka usuku ngalunye - kanye nokwanda okwethusayo kwamacala ezweni lonke - kuyaqondakala uma unemibuzo yokuthi ungahlala kanjani uvikelekile, noma ngabe ugonywe ngokuphelele. Futhi ngenkathi izingxoxo zokudutshulwa okungenzeka kwe-COVID-19 zidlange emasontweni ambalwa edlule, ukuthola umthamo owengeziwe kuzoba ngokoqobo kwabanye maduze.

Abaphathi beFood and Drug Administration bagunyaze imithamo yesithathu yemithi yokugoma emibili iModerna nePfizer-BioNTech COVID-19 yabantu abangenalo igciwane, inhlangano imemezele ngoLwesine. Lesi sinyathelo siza njengoba ukwehluka okutheleleka kakhulu kweDelta kuqhubeka nokukhuphuka ezweni lonke, kubalwa amaphesenti angama-80 wamacala e-COVID-19 e-U.S., Ngokusho kwedatha yakamuva evela kuCenters for Disease Control and Prevention. (Okuhlobene: Usebenza Kangakanani Umgomo we-COVID-19?)

Yize i-coronavirus ibeka usongo olusobala kubo bonke, ukuba nesimiso sokuzivikela komzimba esibuthakathaka - okuyisimo esicishe sibe ngamaphesenti amathathu abantu base-US - "kungakwenza ugule kakhulu ngenxa ye-COVID-19," ngokusho kwe-CDC. Inhlangano ikubonile ukungavunyelwa ukuba ngumzimba njengabantu abathola ukufakelwa izitho zomzimba, labo abelashwa imdlavuza, abantu abane-HIV / AIDS, nalabo abanezifo ezitholwe njengefa ezithinta amasosha omzimba, phakathi kwabanye. I-FDA ikhiphe abezindaba ngoLwesine ukuthi abantu abazofanelekela ukudutshulwa okwesithathu bafaka abamukeli bokufakelwa izitho eziqinile (njengezinso, izibindi, nezinhliziyo), noma labo abangenakuyekelwa okufanayo.

"Isenzo sanamuhla sivumela odokotela ukuthi bakhuphule amasosha omzimba kubantu abathile abangakwazi ukuzivikela abadinga ukuvikelwa okwengeziwe kwi-COVID-19," kusho uJanet Woodcock, MD, obambe njengoKhomishani we-FDA, esitatimendeni ngoLwesine.

Ucwaningo ngethamo lesithathu lomgomo we-COVID-19 kwabakhubazekile belulokhu luqhubeka isikhathi eside. Muva nje, abacwaningi bakwa-John Hopkins Medine baphakamise ukuthi kunobufakazi obubonisa ukuthi imithamo emithathu yomgomo ingakhuphula kanjani amazinga amasosha omzimba ngokumelene ne-SARS-SoV-2 (aka, igciwane elibangela ukutheleleka) kwabamukeli bokufakelwa isitho esiqinile, uma kuqhathaniswa nedosi emibili. imigomo. Ngenxa yokuthi abantu abafakelwa izitho zomzimba ngokuvamile kudingeke ukuthi badle izidakamizwa “ukucindezela amasosha omzimba futhi bavimbele ukwenqatshwa” kokufakelwa, ngokocwaningo, kunokukhathazeka ngekhono lomuntu lokudala amasosha omzimba ngokumelene nezinto zangaphandle. Ngamafuphi, abahlanganyeli abangama-30 ocwaningweni abangama-30 babika amasosha omzimba angatholakali angazwani ne-COVID-19 yize egonywe ngokuphelele. Yize, lapho ethola umthamo wesithathu, ingxenye yesithathu yeziguli yabona ukwanda kwamazinga e-antibody. (Funda kabanzi: Nakhu Konke Odinga Ukukwazi NgeCoronavirus kanye Nokushoda Kokuzivikela Emzimbeni)

Ikomidi Eliluleka Ngezikhungo Zokulawulwa Kwezifo Nokuvimbela Izifo mayelana Nemikhuba Yokugoma kulindeleke lihlangane ngoLwesihlanu ukudingida ezinye izincomo zomtholampilo maqondana nabantu abangenalo igciwane. Kuze kube manje, amanye amazwe asevele egunyaze imithamo ye-booster yabantu abangenawo amandla omzimba, okubandakanya iFrance, iJalimane neHungary, ngokusho kombiko. I-New York Times.

Njengamanje, ama-booster awakagunyazwa labo abanamasosha omzimba anempilo, ngakho-ke kusabalulekile ukuthi bonke abantu abafanelekela umgomo we-COVID-19 bawuthole. Ngokuhambisana nokugqoka amaski, ukubheja okuqinisekile ukuvikela labo abanamasosha omzimba abuthakathaka nanoma ngubani ongakasitholi isibhamu.

Imininingwane ekule ndaba inembile njengesikhathi sokushicilela. Njengoba izibuyekezo mayelana ne-coronavirus COVID-19 ziqhubeka nokuvela, kungenzeka ukuthi ulwazi oluthile nezincomo kule ndaba kushintshile kusukela ekushicilelweni kokuqala. Sikukhuthaza ukuthi uhlole njalo izinsiza ezifana ne-CDC, i-WHO, kanye nomnyango wezempilo womphakathi wendawo ukuze uthole imininingwane yakamuva nezincomo.

Buyekeza kwe-